aglatimagene besadenovec
candel therapeutics
['sclc', 'lcsm,(-blcsm)', 'can-2409', 'nsclc']
phase ii data with can-2409, virally mediated cytotoxic io in pts with nsclc- with either stable or ds progression following first line ici based therapy- 35 treated, 20 evaluable for response - 2 prs, w/ early hints of immune activity #lcsm #asco22 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | Faculty @PC31 | Associate Director @PennPrecisMed | Tweets my own